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Abstract
Background: Adrenomedullin (ADM), a novel vasorelaxant peptide, was found in human/rat ovaries. The present
study investigated the interaction of ADM and endothelin-1 (ET-1) in follicles and newly formed corpora lutea (CL)
and the actions of ADM on progesterone production in CL during pregnancy.
Methods: The peptide and gene expression level of adrenomedullin in small antral follicles, large antral follicles
and CL was studied by real-time RT-PCR and EIA. The effect of ADM treatment on oestradiol production in 5-day
follicular culture and on progesterone production from CL of different pregnant stages was measured by EIA. The
interaction of ADM and ET-1 in follicles and CL at their gene expression level was studied by real-time RT-PCR.
Results: In the rat ovary, the gene expression of Adm increased during development from small antral follicles to
large antral follicles and CL. In vitro treatment of preantral follicular culture for 5 days with ADM increased
oestradiol production but did not affect follicular growth or ovulation rate. The regulation of progesterone
production by ADM in CL in culture was pregnancy-stage dependent, inhibitory at early and late pregnancy but
stimulatory at mid-pregnancy, which might contribute to the high progesterone production rate of the CL at mid-
pregnancy. Moreover, the interaction between ADM and ET-1 at both the production and functional levels
indicates that these two vasoactive peptides may form an important local, fine-tuning regulatory system together
with LH and prolactin for progesterone production in rat CL.
Conclusions: As the CL is the major source of progesterone production even after the formation of placenta in
rats, ADM may be an important regulator in progesterone production to meet the requirement of pregnancy.
Background
First discovered in human pheochromatocytoma tissue
in 1993 [1], adrenomedullin (ADM) is highly conserved
across species [2-5] and is widely expressed in various
organs and tissues, including heart, kidney, lung, adrenal
gland [6] and reproductive organs, such as the ovary
[7-10], the uterus [7,11], the oviduct [12], the testis
[13-16], the prostate [17,18], and the epididymis [19].
ADM belongs to the calcitonin family with a high
sequence homology to calcitonin gene-related peptide
(CGRP). ADM can bind to the CGRP receptor in several
types of tissues [20,21], but specific ADM receptors that
are insensitive to CGRP receptor antagonist have been
identified [22]. McLatchie et al. [23] demonstrated that
the combination of calcitonin receptor-like receptor
(CRLR) and receptor activity-modifying protein (RAMP)
isoforms determines the ligand selectivity for CGRP and
ADM. Coexpression of CRLR with RAMP1, RAMP2
and RAMP3 produces a CGRP receptor, an ADM1 and
ADM2 receptor respectively.
ADM and its mRNA were reported in the follicles and
the corpora lutea (CL) of rat [7] and human [9] ovaries
and the levels varied during the oestrous cycle [12] or
menstrual cycle [10]. In human ovary, Adm mRNA
levels were low in the mature follicle but increased in
the CL of the mid-luteal phase and remained high in CL
of early pregnancy [9]. Immunoreactive ADM is predo-
minantly localized in granulosa lutein cells at the mid-
luteal phase and at late luteal phase [10]. ADM was also
detected in human follicular fluid [10,24,25], with a level
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gesterone production in human granulosa cells [10] but
suppresses eCG-stimulated progesterone release in
newly-formed eCG-primed rat CL [12]. On the other
hand, endothelin-1 (ET-1) is known to inhibit progester-
one production in the rat CL [26]. The interactions of
ADM and ET-1 have been demonstrated in vascular
smooth muscle cells (VSMC) [27-29], the glomerular
mesangial cells (MC) in the kidney [30-32], the zona
glomerulosa cells (ZGC) of the adrenal gland [33], and
Leydig cells [15] and Sertoli cells [16] of the rat testis.
In both the Leydig and Sertoli cells, ADM decreases
ET-1 level but ET-1 increases ADM level [15,16]. The
present study investigated the interaction of ADM and
ET-1 in follicles and newly-formed CL and the action of




Sprague-Dawley rats were obtained from the Laboratory
Animal Unit, LKS Faculty of Medicine, the University of
Hong Kong. The rats were housed at a constant tem-
perature, humidity, under a 12-hour light-dark cycle
(dark period 07:00 to 19:00) and rat chow and water
were available ad libitum. All procedures related to ani-
mal usage were approved by the Committee on the Use
of Live Animals for Teaching and Research, the Univer-
sity of Hong Kong.
Superovulation was induced in 21-23 days old imma-
ture female rats by intraperitoneal (i.p.) injection with
30IU per rat equine chorionic gonadotropin (eCG) and
20IU per rat human chorionic gonadotropin (HCG). An
eCG injection was administered at 3:00 p.m. followed by
a HCG injection 48 h thereafter. Small antral follicles
(SAF) with a diameter between 250 μm-4 0 0μma n d
large antral follicles (LAF) of a diameter over 900 μm
were isolated at 24 and 48 h post-eCG treatment.
Newly-formed CL was isolated 24 h after HCG treat-
ment. All rats were sacrificed by an overdose of sodium
pentobarbital (40 mg/100 g of rat, Alfasan, Woerden,
Holland). Follicles and CL were isolated in ice-cold nor-
mal saline under a dissecting microscope using two
26G1/2 inch syringe needles. The mRNA levels of Adm
and its receptor components - Crlr, Ramp1, Ramp2 and
Ramp3 together with Et1 were studied by real-time RT-
PCR. To study the tissue level of ADM peptide and its
secretion, isolated small antral follicles, large antral folli-
cles, and CL from 5 rats were pooled together and
divided randomly into a 24-well plate at 9 small antral
follicles, 3 large antral follicles or 3 CL per well. Follicles
and CL were pre-incubated for 1 h in 0.5 ml DMEM/F-
12 medium (Invitrogen life technologies, Carlsbad, CA,
USA) and then incubated for another 6 h. The
incubation was carried out at 37°C under 95% humidity
and 5% CO2.A tt h ee n do ft h ei n c u b a t i o n ,c u l t u r e
media and, follicles or CL was collected for ADM
measurement.
Effect of ADM on follicular development
Female 21-23 day old SD rats were sacrificed by an
overdose of sodium pentobarbital (40 mg/100 g of rat,
Alfasan, Woerden, Holland). Their ovaries were
removed and transferred to a pre-warmed follicle isola-
tion medium - Leibovitz’sL - 1 5m e d i u m( I n v i t r o g e nl i f e
t e c h n o l o g i e s ,C a r l s b a d ,C A ,U S A )w i t h0 . 1 %B S A ,p H
7.6. The ovaries were washed once with L-15 medium,
cut into 2-3 pieces each and then transferred to an ovar-
ian-tissue digestion medium (1 × aMEM with 2 mg/ml
collagenase, 0.2 mg/ml DNase I; Gibco BRL, Grand
Island, NY, USA). Digestion was carried out in a 37°C
incubator for about 5 min and then stopped by washing
the ovarian tissues with a pre-warmed L-15 medium.
The ovarian tissues were further incubated in a fresh L-
15 medium for 15-30 min in a 37°C incubator. Preantral
follicles (diameter of 170-210 μm) were dissected out,
washed for 3 times by 1 × DMEM/F-12 medium and
transferred into 96-well plate, one for each well with
100 μl follicle culture medium (1 × aMEM with 5 μg/
ml insulin, 10 μg/ml transferring, 25 μg/ml ascorbic
acid, 1 ng/ml sodium selenite, 5 IU/ml FSH, 0.25 IU/ml
LH, 5% FBS) and pre-incubated at 37°C for 3 h. Then
the culture medium was replaced with a new follicle
culture medium with or without 100 nM ADM. The fol-
licular “diameter” (which is the average value of the
length and width) was measured under an inverted
microscope to make sure they were within 170 - 210
μm. This was recorded as day 0 measurement. The folli-
cles were cultured in an inverted 96-well plate in a 37°
C, 95% humidity and 5% CO2 incubator. Fresh follicle
culture medium was changed every other day. The “dia-
meter” of each follicle was measured on days 1, 2 and 4.
The culture medium for incubation from day 2 to day 4
(48 h incubation) was collected and the oestradiol was
assayed by an EIA kit.
ADM and ET-1 interaction in follicles and CL and
regulation of ADM by progesterone and HCG
The interaction of ADM and ET-1 in large antral follicles
and newly-formed CL from superovulation model was stu-
died. Follicles from 5 rats were pooled together and
divided randomly into a 24-well plate at 3 follicles per
well. They were pre-incubated for 1 h in 0.5 ml DMEM/F-
12 medium. The medium was then replaced and receptor
antagonists, 1 μM hADM22-52 or 1 μM hCGRP8-37 (Phoe-
nix Pharmaceuticals, Burlingame, CA) was added into the
culture medium and incubated for 1/2 h. After that 100
nM ADM (Phoenix Pharmaceuticals, Burlingame, CA)
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another 6 h. Pre-incubated follicles were also treated with
100 nM ET-1 (Phoenix Pharmaceuticals, Burlingame, CA).
All the incubations were carried out at 37°C under 95%
humidity and 5% CO2.A st oC L ,C Lf r o m6 - 8r a t sw e r e
pooled together and divided randomly into a 24-well plate
at 3 CL per well in 0.5 ml medium. The incubation proce-
dure was the same as that of follicles. At the end of the
incubation, culture media was collected for the measure-
ment of ADM or ET-1 by enzyme immunoassay (EIA).
Follicles/CL were harvested for protein measurement for
the normalization of peptide production or for the study
of the gene expression levels of Adm and Et1 and their
respective receptor components.
To study the effects of progesterone and HCG, 10
nmol/L progesterone or 0.75 IU/ml HCG was added
into the culture medium after 1 h pre-incubation. After
6 h incubation, the CL was harvested to determine the
mRNA levels of Adm and its receptor components by
real-time RT-PCR.
Short-time incubation of CL from pregnant rats
Proestrus females were caged with proven fertile males
overnight and the presence of vaginal sperm in the fol-
lowing morning was taken as evidence of successful
copulation. This was day 1 of pregnancy. To study the
effect of ADM on steroidogenesis, CL from ovaries of
7-day, 12-day and 17-day pregnant rats were isolated
under a dissecting microscope with two 26G1/2 syr-
inge needles in ice-cold normal saline. CL from 5-6
rats of each gestational age were dissected out, pooled
and randomly divided into a 24-well plate at 3-4 CL
per well in 0.5 ml DMEM/F-12 medium. First, the iso-
lated CL was pre-incubated in 37°C for 1 h. The med-
ium was replaced and a receptor antagonist, 1 μM
hADM22-52 or 1 μMh C G R P 8-37, was added into the
culture medium and incubated for 1/2 h. After that
100 nM ADM was added into the culture medium. At
the end of 6 h incubation, the culture medium was
collected for the measurement of progesterone produc-
tion by EIA. The CL was harvested for protein mea-
surement by a Pierce BCA protein assay kit (Thermo
Scientific, Rockford, IL, USA) for the normalization of
the hormone production.
Short-time incubation of placenta
The placentae of 12-day and 17-day pregnant rats were
dissected out, and each was cut into 16 or 32 pieces in
ice-cold normal saline. Three pieces of placenta tissue
were randomly distributed in one well of a 24-well
plate. The incubated procedure was the same as that for
the short-time incubation of CL, except that the volume
of the culture medium was 1.0 ml instead of 0.5 ml.
The culture media and placenta tissues were collected
for progesterone EIA and protein normalization by
Pierce BCA protein assay respectively.
Genes expression of Adm, Crlr, Ramp1, Ramp2, Ramp3,
Et1, Eta and Etb
Total RNA of the follicles and corpus luteum were
extracted using TRIZOL reagent and subjected to real-
time RT-PCR analysis. RNA samples (1 μg) were reverse
transcribed into cDNA with the iScript reverse tran-
scriptase according to the manufacturer’si n s t r u c t i o n s
(Bio-Rad Laboratories, Hercules, CA). The real-time RT-
PCR setup was previously described [12]. The reaction
mixtures contained 25 μl iQ SYBR Green Supermix
(Bio-Rad Laboratories, Hercules, CA), 500 nM of each
primer, 1 μl template cDNA, and DNase-free water to a
final volume of 50 μl. Cycle conditions were 95°C for 10
min, followed by 40 cycles of 95°C for 45 sec, 59°C for
30 sec, and 72°C for 45 sec. The reaction was completed
with a dissociation step for melting point analysis from
50°C to 95°C (in increments of 0.5°C for 10 sec each.
The primers were designed on the basis of the published
sequences of Adm (caggacaagcagagcacgtc, forward;
tctggcggtagcgtttgac, reverse); Crlr (ccaaacagacttgggagt-
cactagg, forward; gctgtcttctctttctcatgcgtgc, reverse);
Ramp1 (cactcactgcaccaaactcgtg, forward; cagtcatgag-
cagtgtgaccgtaa, reverse); Ramp2 (aggtattacagcaacctgcggt,
forward; acatcctctgggggatcggaga, reverse); Ramp3
(acctgtcggagttcatcgtg, forward; acttcatccggggggtcttc,
reverse); Et1(tctcttgcctcttcttgctgtc, forward;
gaaactccgccctgctatgg, reverse); Eta (ccgtctatgatgagatgga-
taag, forward; ggttgccaggttaatgcc, reverse) Etb (ccgtgcga-
gactgaaaac, forward; ccgagaagagatggtgtgg, reverse) and
Actb (ggaaatcgtgcgtgacatta, forward; aggaaggaaggctggaa-
gag, reverse). Standard curves for each gene product
were prepared using serial dilution of the cDNA to
determine PCR efficiency. The PCR efficiencies for
Adm, Crlr, Ramp1, Ramp2, Ramp3, Et1, Eta and Etb
and Actb were all above 0.95 and similar. The relative
gene expression levels normalized to Actb were analyzed
using the ΔΔCT method, where CT was the cycle
threshold. Melt curve analysis for each primer set
revealed only one peak for each product. The size of the
PCR products was confirmed by comparing the size of
product with a commercial ladder after agarose gel
electrophoresis.
Extraction of peptides from culture medium
The peptides in the culture medium were extracted,
purified and concentrated by reversed-phase extraction
using Sep-Pak
® Vac C18 Cartridges (200 mg, Waters
Corp., Milford, Massachusetts, USA). The peptides in
t h ee l u a t ew e r et h e nc o n c e n t r a t e db yaS a v a n ts p e e d -
vacuum concentrator (Savant, Farmingdale, NY, USA)
for 2 h and freeze-dried in a lypholizer (Labconco Corp,
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was re-constituted in 1 × EIA assay buffer. The peptide
level in the culture medium was normalized by the
amount of protein in the tissue as measured by the
Pierce BCA protein assay kit.
Extraction of peptides from follicles and CL
Follicles and corpora lutea were homogenized in 2 N
ice-cold acetic acid and then boiled for 10 min. A 50 μl
aliquot was taken for Bio-Rad protein assay (Bio-Rad
Laboratories, Hercules, CA) for normalization. The
remaining homogenates were centrifuged at 18, 600 × g
for 20 min at 4°C. The supernatants were lyophilized
and stored at -20°C until assayed for ADM
immunoreactivity.
Enzyme Immuno Assay (EIA)
An ADM 1-50 (rat) EIA kit (Phoenix Pharmaceuticals,
Inc, Burlingame, CA, USA) was employed to measure
ADM. The minimum detectable concentration is 0.15
ng/ml and the range is 0-100 ng/ml. The intra-assay
error and inter-assay error were less than 5% and 14%
respectively. ET-1 was measured with an ET-1 EIA kit
(Phoenix Pharmaceuticals, Inc, Burlingame, CA, USA).
The minimum detectable concentration is 0.1 ng/ml
and the range is 0-25 ng/ml. The intra-assay error and
inter-assay error were less than 5-10% and 15%
respectively.
The progesterone EIA kit (MP Biomedicals, NY) has a
minimum detectable concentration of 0.3 ng/ml and a
range of 0-50 ng/ml. The intra-assay error and inter-
assay error for this progesterone EIA kit is 2.4% and
2.6% respectively. The oestradiol EIA kit (MP Biomedi-
cals, NY) has a minimum detectable concentration of 10
pg/ml and a range of 0-1000 pg/ml. The intra-assay
error and inter-assay error for oestradiol EIA kit is 4.9%
and 6.6% respectively.
Statistical analysis
All data were expressed as mean ± SEM, and statistical
significance was assessed by one-way ANOVA followed
by Fisher’s least significant difference test for post-hoc
comparisons. Statistical significance was taken at the P
< 0.05 level.
Results
ADM and gene expression of Adm and its receptor
components in follicles and CL
The gene expression level of Adm and Ramp2 in large
antral follicles and CL were much higher than those in
small antral follicles (Figure 1A), while the expression
levels of Crlr, Ramp1 and Ramp3 showed no significant
difference (Figure 1A). There was no significant differ-
ence in the gene expression levels in either Adm or its
receptor components between LAF and CL. After 6 h
incubation, large antral follicles secreted more, and CL
secreted less, ADM into the medium than small antral
follicles (Figure 1B). The tissue levels of ADM peptide
were lower in large antral follicles and CL compared
with small antral follicles (Figure 1B).
Interaction of ADM and ET-1 in follicles
After 6 h incubation, ET-1 reduced ADM secretion and
the mRNA levels of Adm and Ramp1,b u tn o tCrlr,
Ramp2 and Ramp3, in the large antral follicle (Figure
2A). On the contrary, ADM treatment up-regulated Et1
mRNA levels without affecting those of Eta and Etb
receptors and ET-1 secretion (Figure 2B). The stimula-
tory effect of ADM on Et1 expression could not be
abolished by either hADM22-52 (an ADM receptor
antagonist) or hCGRP8-37 (a CGRP receptor antagonist)
(Figure 2B).
Interaction of ADM and ET-1 in CL and regulation of ADM
expression by progesterone and HCG
ET-1 reduced Adm gene expression and ADM secretion
in the CL after 6 h incubation (Figure 3A) while ADM
treatment increased Et1 expression level, an effect which
was abolished by a CGRP receptor blocker - hCGRP8-37
(Figure 3B). Both progesterone and HCG suppressed
Adm expression but had no significant effect on the
expression levels of Crlr, Ramp1, Ramp2 or Ramp3 (Fig-
ure 4).
Effect of ADM on follicular growth and oestradiol
secretion
The cultured follicles were examined daily under micro-
scopy. Most of the cultured preantral follicles increased
in size and their diameter increased from 185.9 ± 3.1
μm to 347.6 ± 18.0 μm after 96 h incubation. There was
no significant difference in follicular size between the
control and ADM-treated group after 24 h, 48 h and 96
h incubation. However, oestradiol secretion into the cul-
ture medium of ADM-treated group (960.8 ± 136.1 pg/
follicle) was significantly higher than the control group
(600.5 ± 98.8 pg/follicle).
Effect of ADM on progesterone production from CL and
placenta of pregnancy
As shown in Figure 5A, the basal rates of progesterone
production from CL of early, mid- and late pregnant
rats were different, with the highest progesterone pro-
duction rate at mid-pregnancy. Treatment with 1 nM or
10 nM ADM had no effect on progesterone production
(data not shown). However, 100 nM ADM showed dif-
ferent effects on progesterone production in CL at dif-
ferent stages of gestation - inhibitory in early pregnancy
(Figure 5B) and late pregnancy (Figure 5D) but
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Figure 1 The peptide and gene expression levels of adrenomedullin in follicles and corpus luteum (CL). The gene expression levels of
Adm, its receptor components and Et1 in small antral follicles (SAF), large antral follicles (LAF) and newly-formed corpus luteum (CL) (A); tissue
levels of ADM and secreted ADM levels from SAF, LAF and CL after 6 h incubation (B). n = 5. * P < 0.05 compared with SAF; #P < 0.05
compared with LAF.
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Figure 2 Interactions of ADM and ET-1 in large antral follicles. ET-1 reduced the gene expression levels of Adm and Ramp1, and the ADM
peptide secretion level (A); ADM treatment up-regulated Et1 gene expression level (B). Data were presented as mean ± SEM. n = 5; *P < 0.05
compared with control.
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Figure 3 Interactions of ADM and ET-1 in corpus luteum (CL). ET-1 reduced Adm and Ramp1 gene expression and ADM secretion in the CL
(A); ADM treatment increased Et1 expression level, which was reversed by a CGRP receptor blocker - hCGRP8-37 (B). n = 6-8; *P < 0.05 compared
with control, #P < 0.05 compared with 100 nM ADM treatment group.
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tory effect in early pregnancy and the stimulatory effect
at mid-pregnancy were reversed by the CGRP receptor
antagonist, hCGRP8-37.
The secretion level of progesterone from the placenta
was extremely low compared with those in CL, with
11.4 ± 4.7 and 3.6 ± 0.2 nmol/g protein/6 h for placenta
of mid- and late pregnancy respectively. A CL produced
much more progesterone than a placenta (184.4 ± 50.2
and 208.9 ± 32.3 picomol per CL vs 19.4 ± 17.5 and
19.4 ± 2.7 picomol per placenta at mid- and late preg-
nancy). ADM had no effect on progesterone production
in placentae (data not shown).
Discussion
In the rat, the recruitment of follicles into the ovulatory
cohort occurs around the time of antrum formation
with a follicle diameter of about 200-400 μm, concomi-
tant with the atresia of most of the follicles [34]. Ovula-
tion occurs when the follicles reach a size of 900-1000
μm in diameter [34]. The finding of a higher ADM
secretion and Adm mRNA level in large antral follicles
and CL compared with small antral follicles agrees well
with the previous qualitative description of increased
ADM and Adm mRNA expression in the human CL [9],
and suggests a possible role of ADM in follicle develop-
ment, luteogenesis and/or steroidogenesis. High Ramp2
gene expression levels in large antral follicles and CL
compared to small antral follicles suggests a possible
further augmentation of ADM function through the
increase in an ADM receptor.
After a short 6-h incubation, large antral follicles
secreted the largest amount of ADM peptide into the
medium. High ADM level in human follicular fluid has
been reported and the pre-ovulatory level is even higher
than the plasma ADM concentration [10,24,25]. The
possible function of secreted ADM from the large antral
follicles remained unknown. After ovulation the ADM
in the residual follicular fluid that enters the oviduct
together with the oocyte may exert biological actions in
the fallopian tube and the uterus, such as the regulation
of blood flow [35], sperm transportation [36,37] and
uterine contraction [10].
ADM at the dose of 100 nM had no effects on the fol-
licular size and follicular survival rate. In the heterozy-
gous Adm knockout mouse with decreased Adm
expression and reduced fertility, there was also no sig-
nificant decrease in ovulation, fertilization rate or overt
Figure 4 Regulation of gene expression of Adm and its receptor components in the corpus luteum (CL) by progesterone and HCG.
Progesterone and HCG both suppressed Adm expression. n = 5; *P < 0.05 compared with control.
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Figure 5 Progesterone production from corpus luteum (CL) of early (7-day), mid- (12-day) and late (17-day) pregnant rats (A) and the
effects of ADM treatment on progesterone production after 6 h incubation. ADM suppressed progesterone production in CL from early (B)
and late pregnancy (D), while increased progesterone production in CL from mid-pregnancy, which was diminished by co-treatment with
hCGRP8-37 (C). Data were presented as mean ± SEM. n = 5-6.
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other hand, ADM was found to stimulate oestradiol pro-
duction from the follicles, suggesting a role for ADM in
steroidogenesis rather than granulosa cell proliferation.
The relative high levels of ADM and the gene expres-
sion level of Adm and Ramp2 in the newly-formed CL
also suggested that ADM might be involved in CL for-
mation or luteal functions. Indeed our group has
reported an inhibitory effect of ADM on eCG-stimu-
lated progesterone secretion from CL [12]. The CL
employed in that report were isolated from eCG primed
rats, which were not fully functional as compared to the
CL of pregnant rats. We therefore used CL from early,
mid- and late pregnant rats for this study. It is of inter-
est to note that ADM showed opposite effects on pro-
gesterone production depending on the pregnancy stage,
inhibitory in CL from early and late pregnant rat while
stimulatory in CL from mid-pregnant rats. This dual
role of ADM in progesterone production may partly
explain for the differences in the basal progesterone pro-
duction from the CL at different pregnancy stages. CL
of mid-pregnancy producedt h eg r e a t e s ta m o u n to f
ADM when the effect of ADM is stimulatory, not for-
getting that the low basal progesterone secretion from
the CL of late pregnancy could be due to the decrease
in LH and prolactin secretion from early pregnancy
onwards [39] while the increase in progesterone produc-
tion in mid-pregnancy could be due to the secretion of
placental luteotopin with prolactin activity from day 6
to day 11 of pregnancy [40]. Prolactin [41] and placental
luteotropins [42] are known to stimulate luteal proges-
terone production
The difference in ADM effects on progesterone pro-
duction cannot be simply due to the binding to differ-
ent receptors as both the inhibitory effect in early
pregnancy and the stimulatory effect in mid-pregnancy
were blocked by the CGRP receptor antagonist. In late
pregnancy, the inhibitory effect was more likely
mediated by the ADM receptor. A similar dual effect
has been reported for the actions of progesterone on
prolactin secretion, with a stimulatory effect in early
pregnancy (day 7) and an inhibitory effect in late preg-
nancy (day 17) [43]. The suppressive action of proges-
terone on Adm gene expression may suggest the
presence of a negative feedback between ADM and pro-
gesterone. The inhibitory effect of hCG on CL Adm
gene expression is in line with the FSH effect in the fol-
licles [8].
Compared with CL, the progesterone production from
placenta was minor. This is consistent with existing lit-
erature that the progesterone production in rat CL was
not taken over by placenta from mid-pregnancy
onwards, unlike the situation in human pregnancy [44].
In our study, progesterone production of the placenta
decreased from mid-pregnancy to late pregnancy, in line
with the finding of Matt and MacDonald [44].
It was found that in both the follicle and CL, ADM
and ET-1 showed opposite regulatory effect on each
other, indicating the presence of an autocrine/paracrine
regulatory loop between ADM and ET-1. ADM stimu-
lated the gene expression level of Et1 in the CL, an
effect which is abolished by CGRP receptor blocker -
hCGRP8-37. As ET-1 was reported to inhibit progester-
one production in the rat CL [26], the stimulatory effect
of ADM on Et1 gene expression might in turn suppress
progesterone production. On the other hand, ET-1
treatment suppressed both the ADM peptide secretion
and its gene expression in CL. This finding is opposite
to the results in both the Leydig and Sertoli cells, in
which ADM decreases ET-1 level but ET-1 increases
ADM level [15,16]. It suggests that besides a direct inhi-
bitory effect, ET-1 may also fine-tune progesterone pro-
duction through its suppressive effects on ADM
secretion and Adm gene expression. In addition to the
functional interaction of ADM and ET-1 in regulating
progesterone, in the CL, ADM may also have actions
opposite to those of ET-1 in luteolysis. ET-1 is sug-
gested to be luteolytic [26,45] while ADM may be anti-
luteolytic [9] by maintaining adequate luteal blood flow
as a vasodilator.
Conclusions
In conclusion, the gene expression of Adm and ADM
secretion increased with the change from small antral
follicles to large antral follicles and CL. ADM in the fol-
licle was involved in steroidogenesis. In CL of preg-
nancy, the regulation of ADM on progesterone
production was pregnancy stage - dependent, inhibitory
in CL from early and late pregnancy while stimulatory
at mid-pregnancy. Moreover, there was the interaction
between ADM and ET-1 at both the production and
functional levels in CL. Besides prolactin and placental
luteotropins, ADM may be an important regulator in
progesterone production during pregnancy, being itself
under the inhibitory effects of LH, progesterone and
ET-1.
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